FDA Inspection 729029 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3008629223

The FDA completed an inspection of Oklahoma Blood Institute on Jun 9, 2011 in Hot Springs, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 9, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hot Springs, AR (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.